Development and validation of an ELISA kit (YF MAC-HD) to detect IgM to yellow fever virus

Journal of Virological Methods

Volumn 225, Issue , 2015, Pages 41-48

  Basile, Alison Jane ^a   Goodman, Christin ^a   Horiuchi, Kalanthe ^a   Laven, Janeen ^a   Panella, Amanda J ^a   Kosoy, Olga ^a   Lanciotti, Robert S ^a   Johnson, Barbara W ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Diagnostic; ELISA; IgM; Kit; Yellow fever virus

Indexed keywords

IMMUNOGLOBULIN M; VIRUS ANTIGEN; DIAGNOSTIC KIT; VIRUS ANTIBODY;

ARTICLE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELISA KIT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MICROTITER PLATE ASSAY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PUBLIC HEALTH SERVICE; SERUM; SHELF LIFE; STORAGE TEMPERATURE; VALIDATION PROCESS; VIRUS DETECTION; YELLOW FEVER VIRUS; AFRICA; BLOOD; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; PROCEDURES; SEROLOGY; TEMPERATURE; YELLOW FEVER;

AFRICA; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN M; REAGENT KITS, DIAGNOSTIC; SEROLOGIC TESTS; TEMPERATURE; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 84941909464     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2015.08.025     Document Type: Article

References (21)

1. Bessoff K., Phoutrides E., Delorey M., Acosta L., Hunsperger E. Utility of a commercial nonstructural protein 1 antigen capture kit as a dengue virus diagnostic tool. Clin. Vaccine Immunol. 2010, 17:949-953.
2. CDC, 2015. http://www.cdc.gov/yellowfever/symptoms/index.html.
3. Chiou S.-S., Crill W., Chen L.-K., Chang G.-J. Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections. Clin. Vaccine Immunol. 2008, 15:825-835.
4. Goodman C.H., Russell B.J., Velez J.O., Laven J.J., Nicholson W.L., Bagarozzi D.A., Moon J.L., Bedi K., Johnson B.W. Development of an algorithm for production of inactivated arbovirus antigens in cell culture. J. Virol. Methods 2014, 208:66-78.
5. Hunsperger E., Yoksan S., Buchy P., Nguyen V., Sekaran S., Enria D., Vazquez S., Cartozian E., Pelegrino J., Artsob H., Guzman M., Olliaro P., Zwang J., Guillerm M., Kliks S., Halstead S., Peeling R., Margolis H. Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody. PLoS Negl. Trop. Dis. 2014, 8:e3171.
6. Jain N.K., Roy I. Trehalose and protein stability. Curr. Protoc. Protein Sci. 2010, (Chapter 4:Unit 4.9).
7. Kolosova A., Shim W.-B., Yang Z.-Y., Eremin S., Chung D.-H. Direct competitive ELISA based on a monoclonal antibody for detection of aflatoxin B1 stabilization of ELISA kit components and application to grain samples. Anal. Bioanal. Chem. 2006, 384:286-294.
8. Lindsey H.S., Calisher C.H., Mathews J.H. Serum dilution neutralization test for California group virus identification and serology. J. Clin. Microbiol. 1976, 4:503-510.
9. Martin D.A., Muth D.A., Brown T., Johnson A.J., Karabatsos N., Roehrig J.T. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J. Clin. Microbiol. 2000, 38:1823-1826.
10. McMahon A.W., Eidex R.B., Marfin A.A., Russell M., Sejvar J.J., Markoff L., Hayes E.B., Chen R.T., Ball R., Braun M.M., Cetron M., Yellow Fever Working Group Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases. Vaccine 2007, 25:1727-1734.
11. McNeill J.R. "Yellow Jack" and geopolitics: environment. Epidemics, and the struggles for Empire in the American Tropics, 1650-1825. OAH Mag. Hist. 2004, 18:9-13.
12. Pierce J., Writer J. Yellow Jack: How Yellow Fever Ravaged America and Walter Reed Discovered Its Deadly Secrets 2005, 3. John Wiley & Sons, Hoboken, NJ.
13. Prince H., Yeh C. Reactivity of human IgM binding murine monoclonal 6B6C1 (IgG2a) with other murine monoclonal IgG antibodies. J. Clin. Lab. Anal. 2013, 27:27-30.
14. RCoreTeam R: A Language and Environment for Statistical Computing 2014, R Foundation for Statistical Computing, Vienna, Austria. http://www.r-project.org/.
15. Reed W., Carroll J. The prevention of yellow fever. Public Health Pap. Rep. 1901, 27:113-129.
16. Robinson J.S., Featherstone D., Vasanthapuram R., Biggerstaff B.J., Desai A., Ramamurty N., Chowdhury A.H., Sandhu H.S., Cavallaro K.F., Johnson B.W. Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays. Am. J. Trop. Med. Hyg. 2010, 83:1146-1155.
17. Stokes A.B., Johannes H., Hudson P. Experimental transmission of yellow fever into laboratory animals. Am. J. Trop. Med. Hyg. 1928, 8:103-164.
18. Strode G.K. Yellow Fever 1951, Rockefeller Foundation, International Health Division, McGraw-Hill, New York. first ed.
19. Theiler M., Smith H.H. The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus. J. Exp. Med. 1937, 65:767-786.
20. Tsai T.F., Bolin R.A., Montoya M., Bailey R.E., Francy D.B., Jozan M., Roehrig J.T. Detection of St. Louis encephalitis virus antigen in mosquitoes by capture enzyme immunoassay. J. Clin. Microbiol. 1987, 25:370-376.
21. WHO Yellow Fever. Fact Sheet No. 100 2014.